Quick Comparison
| Azelaic Acid | Kojic Acid | |
|---|---|---|
| Typical Concentration | OTC: 10% (The Ordinary). Prescription: 15% gel (Finacea for rosacea), 20% cream (Azelex for acne). Apply twice daily. Well-tolerated but may sting/itch initially. Full effects at 8-12 weeks. | Concentrations: 1-4%. Kojic dipalmitate is a more stable ester form but less potent. Apply once or twice daily. Often combined with other brightening agents (arbutin, vitamin C, niacinamide). Results visible at 4-8 weeks. |
| Application | Topical (gel, cream, serum). Slightly gritty texture in some formulations. Apply to clean skin. | Topical (serum, cream). Store in airtight, opaque packaging. Discard if the product turns brown. |
| Research Papers | 9 papers | 10 papers |
| Categories |
Mechanism of Action
Azelaic Acid
Azelaic acid exhibits multi-modal activity: (1) Tyrosinase inhibition—competitively inhibits tyrosinase selectively in hyperactive melanocytes (melasma, PIH) while sparing normal ones; may involve mitochondrial enzyme interference in dysregulated melanocytes. (2) Antimicrobial—bacteriostatic against Cutibacterium acnes by inhibiting bacterial protein synthesis. (3) Comedolytic—normalizes follicular keratinization, reducing hyperkeratinization and corneocyte cohesion; may modulate keratinocyte differentiation. (4) Anti-inflammatory—scavenges ROS, inhibits neutrophil free radicals, reduces pro-inflammatory cytokines. Inhibits 5-alpha-reductase in sebocytes, potentially reducing sebum. Multi-pathway activity explains efficacy in acne, rosacea, and hyperpigmentation. Safe during pregnancy.
Kojic Acid
Kojic acid (5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) inhibits tyrosinase through copper chelation—tyrosinase is a type-3 copper enzyme requiring two copper ions to catalyze tyrosine to L-DOPA and L-DOPA to dopaquinone. By sequestering copper, kojic acid renders tyrosinase inactive. May also inhibit tyrosinase-related protein-1 (TRP-1). Exhibits direct antioxidant activity, scavenging superoxide and hydroxyl radicals. Relatively unstable—oxidizes with air and light, forming brown degradation products that lose activity; opaque, airtight packaging and low pH improve stability. Kojic dipalmitate is a more stable ester but requires enzymatic cleavage, reducing potency. Contact sensitization can develop with prolonged use.
Risks & Safety
Azelaic Acid
Common
Stinging, burning, itching on initial application (usually subsides within 2 weeks). Mild dryness.
Serious
None. Safe during pregnancy and breastfeeding.
Rare
Allergic contact dermatitis, hypopigmentation (rare at cosmetic concentrations).
Kojic Acid
Common
Contact sensitization (developing an allergy over time with repeated use), redness, irritation.
Serious
Contact dermatitis in sensitized individuals.
Rare
Paradoxical darkening in very sensitive skin types.
Full Profiles
Azelaic Acid →
A dicarboxylic acid naturally produced by yeast on the skin. Azelaic acid is a true multi-tasker that treats acne, rosacea, and hyperpigmentation simultaneously. It is one of the few active ingredients considered safe during pregnancy, and it uniquely targets only abnormal melanocytes — meaning it brightens dark spots without lightening normal skin. Effective for both inflammatory acne and post-inflammatory hyperpigmentation (PIH).
Kojic Acid →
A natural brightening agent produced as a byproduct of sake and soy sauce fermentation. Kojic acid inhibits tyrosinase by chelating copper, which is required for the enzyme's active site. It is one of the most effective OTC alternatives to hydroquinone for treating hyperpigmentation, melasma, and age spots, though it is less stable in formulation and can cause contact sensitization over time.